The weekly litigation news digest is live. Subscribe now

IP Verse

Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions - EP1968630

The patent EP1968630 was granted to Boehringer Ingelheim on Jan 24, 2018. The application was originally filed on Dec 28, 2006 under application number EP06848471A. The patent is currently recorded with a legal status of "Revoked".

EP1968630

BOEHRINGER INGELHEIM
Application Number
EP06848471A
Filing Date
Dec 28, 2006
Status
Revoked
Jul 17, 2024
Publication Date
Jan 24, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LABORATORIOS HIPRAOct 24, 2018GRUNECKER PATENTADMISSIBLE
ELANCOOct 23, 2018POTTER CLARKSONADMISSIBLE
INTERVETOct 23, 2018INTERVETWITHDRAWN

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2004132178
INTERNATIONAL-SEARCH-REPORTUS6391314
OPPOSITIONAU2003248395
OPPOSITIONEP1926496
OPPOSITIONGB2282811
OPPOSITIONUS2002146432
OPPOSITIONUS2003170270
OPPOSITIONUS6703023
OPPOSITIONUS7122192
OPPOSITIONUS75501505P
OPPOSITIONWO0001409
OPPOSITIONWO2005009462
OPPOSITIONWO2006072065
OPPOSITIONWO2007076520
OPPOSITIONWO9307898
OPPOSITIONWO9418311
SEARCHWO2005009462
SEARCHWO2006072065

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents